What this trial studies
This study will be conducted on 28 participants who are survivors of breast cancer and underwent radiotherapy. The purpose of the current study is to investigate the effect of aerobic exercises on quality of life and serum levels of Zinc, Copper and iron in post-menopausal women who received radiotherapy after surviving breast cancer.
Conditions in scope
- Trace Elements Levels After Breast Cancer Radiotherapy
Interventions
- Aerobic Exercise three time a week (Other) — The participants will receive mild to moderate aerobic exercise for three weeks for 12 sessions.
Who can join
Women only · Ages 50 Years to 60 Years
Inclusion criteria
- All postmenopausal women with breast cancer and received radiotherapy immediately at the end of radiotherapy or max six months to one year in each group. after clinically diagnosed by Oncologist with breast cancer Stage I and II .
- Their ages will range from 50-60 years old.
- Good general Health (ECOG performance status 0-1).
- Voluntary acceptance of participation in the study.
Exclusion criteria
- Systematic chronic diseases (respiratory diseases, cardiovascular diseases…etc)
- Cognitive dysfunction as well as neuromuscular or musculoskeletal impairment or disease affecting postural control or motion pattern.
- Professional athletes.
Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.
Where it’s happening
| City | State / Region | Facility | Site status |
|---|---|---|---|
| Cairo | Cairo Governorate | Tarek Hussein | Unknown |
Status & timeline
- Overall status: Completed
- Study type: Interventional
- Phase: N/A
- Start date: 2023-10-10
- Primary completion: 2025-09-13
- Last update posted: 2026-04-01
- First posted: 2023-10-06
Sponsor & contact
Lead sponsor: Cairo University (Other)
For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.
Outcome measures
Primary outcomes
- trace elements levels (2 months)
Blood testing for Fe, Zn, and Cu elements
Related ClearedRx care
If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.
Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT06070155 before contacting a site.
ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.